I think BD1 has sucked a lot of the momentum from biotech stocks. But between BD1 and BIT, I think MEM has the most promise. We're literally on stage 4 clinical trials, and given the people that the organization has chosen for stage 4 trials, I'm pretty sure their confident that there's going to be positive feedback. worth at least 20 cents a share. I guess MEM isn't as sexy as the other biotech's, being to do with isolating sperm cells. Which is ironic.
Ann: Response to ASX aware query, page-9
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
